JP2004518639A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004518639A5 JP2004518639A5 JP2002544012A JP2002544012A JP2004518639A5 JP 2004518639 A5 JP2004518639 A5 JP 2004518639A5 JP 2002544012 A JP2002544012 A JP 2002544012A JP 2002544012 A JP2002544012 A JP 2002544012A JP 2004518639 A5 JP2004518639 A5 JP 2004518639A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- linear
- branched
- group
- hydrogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 125000000217 alkyl group Chemical group 0.000 claims 61
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 22
- 229910052739 hydrogen Inorganic materials 0.000 claims 22
- 239000001257 hydrogen Substances 0.000 claims 22
- 125000000304 alkynyl group Chemical group 0.000 claims 14
- 150000001875 compounds Chemical class 0.000 claims 14
- 125000003342 alkenyl group Chemical group 0.000 claims 13
- -1 acetoxymethyl Chemical group 0.000 claims 12
- 150000002148 esters Chemical class 0.000 claims 11
- 229960000367 inositol Drugs 0.000 claims 8
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 7
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 7
- 150000003839 salts Chemical class 0.000 claims 7
- NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 claims 5
- 229910019142 PO4 Inorganic materials 0.000 claims 4
- 229910052736 halogen Inorganic materials 0.000 claims 4
- 150000002367 halogens Chemical class 0.000 claims 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims 4
- 239000010452 phosphate Substances 0.000 claims 4
- 239000000126 substance Substances 0.000 claims 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims 3
- 206010061218 Inflammation Diseases 0.000 claims 3
- 230000004054 inflammatory process Effects 0.000 claims 3
- 230000028327 secretion Effects 0.000 claims 3
- 239000003814 drug Substances 0.000 claims 2
- HOXINJBQVZWYGZ-UHFFFAOYSA-N fenbutatin oxide Chemical compound C=1C=CC=CC=1C(C)(C)C[Sn](O[Sn](CC(C)(C)C=1C=CC=CC=1)(CC(C)(C)C=1C=CC=CC=1)CC(C)(C)C=1C=CC=CC=1)(CC(C)(C)C=1C=CC=CC=1)CC(C)(C)C1=CC=CC=C1 HOXINJBQVZWYGZ-UHFFFAOYSA-N 0.000 claims 2
- 230000002401 inhibitory effect Effects 0.000 claims 2
- 230000001105 regulatory effect Effects 0.000 claims 2
- 239000001226 triphosphate Substances 0.000 claims 2
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 claims 1
- HZTJDBWXSVQJFY-UHFFFAOYSA-N [acetyloxymethoxy-[[4,6,7-tris[bis(acetyloxymethoxy)phosphoryloxy]-2,2-dimethyl-7a-propyl-4,5,6,7-tetrahydro-3aH-1,3-benzodioxol-5-yl]oxy]phosphoryl]oxymethyl acetate Chemical compound C(C)(=O)OCOP(=O)(OCOC(C)=O)OC1C(C(C(C2OC(OC21CCC)(C)C)OP(=O)(OCOC(C)=O)OCOC(C)=O)OP(=O)(OCOC(C)=O)OCOC(C)=O)OP(=O)(OCOC(C)=O)OCOC(C)=O HZTJDBWXSVQJFY-UHFFFAOYSA-N 0.000 claims 1
- 230000033228 biological regulation Effects 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 claims 1
- 125000004122 cyclic group Chemical group 0.000 claims 1
- 230000005764 inhibitory process Effects 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- LFGREXWGYUGZLY-UHFFFAOYSA-N phosphoryl Chemical group [P]=O LFGREXWGYUGZLY-UHFFFAOYSA-N 0.000 claims 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25260300P | 2000-11-21 | 2000-11-21 | |
| PCT/US2001/043664 WO2002041831A2 (en) | 2000-11-21 | 2001-11-21 | Inositol derivatives for increasing chloride secretion and inhibiting inflammation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004518639A JP2004518639A (ja) | 2004-06-24 |
| JP2004518639A5 true JP2004518639A5 (enExample) | 2005-12-22 |
Family
ID=22956721
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002544012A Pending JP2004518639A (ja) | 2000-11-21 | 2001-11-21 | 塩化物分泌を増加しそして炎症を阻害するためのイノシトール誘導体 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US7453006B2 (enExample) |
| EP (1) | EP1345950A4 (enExample) |
| JP (1) | JP2004518639A (enExample) |
| AU (1) | AU2002217808A1 (enExample) |
| CA (1) | CA2430190A1 (enExample) |
| WO (1) | WO2002041831A2 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2828206B1 (fr) * | 2001-08-03 | 2004-09-24 | Centre Nat Rech Scient | Utilisation d'inhibiteurs des lysyl oxydases pour la culture cellulaire et le genie tissulaire |
| AU2002327006A1 (en) * | 2001-09-20 | 2003-04-01 | Inologic, Inc. | Method of modulating sodium ion absorption in epithelial cells |
| AU2003231157C1 (en) * | 2002-04-29 | 2009-02-26 | Normoxys, Inc. | Inositol pyrophosphates, and methods of use thereof |
| US20060177517A1 (en) * | 2003-02-26 | 2006-08-10 | Toshikazu Shiba | Antiinflammtory agent and antiinflammatory medical material |
| US20060258626A1 (en) * | 2004-07-06 | 2006-11-16 | Claude Nicolau | Use of inositol-tripyrophosphate in treating tumors and diseases |
| US20060106000A1 (en) * | 2004-07-06 | 2006-05-18 | Claude Nicolau | Use of inositol-tripyrophosphate in treating tumors and diseases |
| US7745423B2 (en) * | 2004-07-06 | 2010-06-29 | NormOxys, Inc | Calcium/sodium salt of inositol tripyrophosphate as an allosteric effector of hemoglobin |
| PL1863495T3 (pl) * | 2005-03-18 | 2015-06-30 | Normoxys Inc | Sól wapniowa 1,6:2,3:4,5-tripirofosforanu mioinozytolu jako efektor allosteryczny hemoglobiny w leczeniu raka |
| AU2006344178A1 (en) * | 2006-06-09 | 2007-12-13 | Erasmus University Medical Center Rotterdam | Modulation of the immune system by inositol phospholipids |
| CN101784193A (zh) * | 2007-05-01 | 2010-07-21 | 诺尔姆奥克西斯公司 | 促红细胞生成素互补或替代 |
| US8414533B2 (en) | 2009-10-08 | 2013-04-09 | Shl Group Ab | Medicament delivery device |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE8605063D0 (sv) * | 1986-11-26 | 1986-11-26 | Matti Siren | Derivatives of cyclohexane |
| FR2694936B1 (fr) * | 1992-08-18 | 1994-11-25 | Bayer Pharma | Dérivés substitués du désoxy-myoinositol, procédé pour leur préparation et leur utilisation dans des médicaments. |
| SE503122C2 (sv) * | 1993-11-22 | 1996-03-25 | Perstorp Ab | Användning av en inositoltrisfosfatester för behandling av inflammatoriska tillstånd |
| US5977078A (en) * | 1996-09-20 | 1999-11-02 | The Regents Of The Univesity Of California | Inositol polyphosphate derivatives and methods of using same |
| AU721150B2 (en) * | 1996-09-20 | 2000-06-22 | Inologic, Inc. | Inositol polyphosphate derivatives and methods of using same |
| US6221856B1 (en) * | 1999-02-03 | 2001-04-24 | Inologic, Inc. | Inositol derivatives for inhibiting superoxide anion production |
-
2001
- 2001-11-21 AU AU2002217808A patent/AU2002217808A1/en not_active Abandoned
- 2001-11-21 US US10/432,340 patent/US7453006B2/en not_active Expired - Fee Related
- 2001-11-21 EP EP01997275A patent/EP1345950A4/en not_active Withdrawn
- 2001-11-21 JP JP2002544012A patent/JP2004518639A/ja active Pending
- 2001-11-21 WO PCT/US2001/043664 patent/WO2002041831A2/en not_active Ceased
- 2001-11-21 CA CA002430190A patent/CA2430190A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2382026C2 (ru) | Аналоги липоксина а4 | |
| RU2000132188A (ru) | Производные эпотилонов, их синтез и применение | |
| CA2334342A1 (en) | Epothilone derivatives and their synthesis and use | |
| JP2004518639A5 (enExample) | ||
| BR9916790A (pt) | Uso de um composto, composto, processo para amanufatura do mesmo, composição farmacêtica, e,método para produzir um efeito de dano vascularem um animal de sangue quente | |
| RU2008106058A (ru) | Производные пиридазинона в качестве агонистов рецептора тиреоидного гормона | |
| HU9300274D0 (en) | Phosphonoxical as well as carbonatic derivatives of taxole and medical preparatives containing said active substance | |
| NO20091344L (no) | Pleuromutilin-derivater, fremgangsmate for fremstilling av disse, farmasoytisk preparat inneholdende disse, disse forbindelsene for anvendelse i terapi samt anvendelse av disse for fremstilling av medikamenter for behandling av sykdom | |
| JP2005504011A5 (enExample) | ||
| KR890011592A (ko) | 기관내 허혈병의 치료용 조성물 | |
| ATE448194T1 (de) | Verwendung einer pharmazeutischen zusammensetzung mit einem para-aminophenylessigsäurederivat für die behandlung von entzündlichen erkrankungen des magen-darmtrakts | |
| KR880006193A (ko) | 피페리딘 화합물 및 그의 제조 및 용도 | |
| DE50108674D1 (de) | Verbindungen mit einer sulfonamidgruppe und diese verbindungen enthaltende pharmazeutische zusammensetzungen | |
| AU8059791A (en) | Ether lipid-nucleoside covalent conjugates | |
| KR960004345A (ko) | 2-(2- 아미노-1,6- 디하이드로-6- 옥소-퓨린-9-일)메톡시-1,3- 프로판 디올 유도체 | |
| DE60044369D1 (de) | Synthetisches oligomannosid, seine herstellung und verwendung | |
| DE69528291D1 (de) | Nicht-beta oxidierbare fettsäureanaloge,deren verwendung als therapeutisch wirksame medikamente sowie deren herstellung | |
| JP2004502732A5 (enExample) | ||
| MY106300A (en) | Prostaglandin analoques for use in medicine | |
| ATE257704T1 (de) | Pharmazeutische zusammensetzungen enthaltend norastemizol. | |
| RU2003134629A (ru) | Соединения цефема | |
| RU96123227A (ru) | Амидные производные и их терапевтическое использование | |
| JP2006504673A5 (enExample) | ||
| IT1196041B (it) | Emichetali di (8s)-8-fluoroeritromicine,il procedimento per la loro preparazione e le formulazioni adatte alla somministrazione orale che contengono i prodotti | |
| JP2003509494A5 (enExample) |